Correction and Update: Axena Health Secures Two More Favorable Insurance Coverage Approvals for Leva
Axena Health Secures Expanded Insurance Coverage for Leva Pelvic Health System Axena Health, Inc. (Axena Health) has achieved a significant milestone in expanding insurance coverage for its Leva® Pelvic Health…
Global Hospital Care Partnering Deals Analysis 2016-2024: Collaboration, Development, and Licensing by Company, Deal Type, and Therapy Area
The latest addition to ResearchAndMarkets.com’s offerings is the “Hospital Care Collaboration and Licensing Deals 2016-2024” report, now fully revised and updated. This comprehensive report delves into hospital care deals spanning…
2019-2024 Pharma Collaboration Report: Upfront, Milestones, Royalties by Company, Therapy, Tech – ResearchAndMarkets.com
The “Collaboration Deals in Pharmaceuticals 2019-2024” report is now available on ResearchAndMarkets.com. This report offers a detailed analysis of collaboration deals in the pharmaceutical industry, explaining why and how companies…
Calidi to Effect Reverse Stock Split
Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or “Company”), a clinical-stage biotechnology firm developing advanced targeted virotherapies, has announced that its Board of Directors has approved a 1-for-10 reverse stock…
Cencora Sets Date and Time for Q3 Fiscal 2024 Earnings Release
Cencora Announces Q3 Fiscal 2024 Earnings Release Date and Conference Call Cencora, Inc. (NYSE: COR) has announced plans to release its Third Quarter Fiscal 2024 results on Wednesday, July 31,…
Nominations Now Open for the Prestigious 2024 Tu Youyou Award
MDPI is delighted to announce the opening of nominations for the 2024 Tu Youyou Award, a prestigious recognition established in honor of Professor Tu Youyou, Nobel Laureate, whose discovery has…
Navidea Biopharmaceuticals, Inc. Releases Findings from Exploratory Analysis Conducted on July 2, 2024
Navidea Biopharmaceuticals, Inc. a company specializing in precision immunodiagnostic agents and immunotherapeutics, has disclosed disappointing findings from an exploratory analysis conducted on its pivotal NAV3-33 clinical trial, titled “Evaluation of…
FDA Approves Roche’s Vabysmo Prefilled Syringe for Three Major Causes of Vision Loss
The United States Food and Drug Administration (US FDA) has approved the Vabysmo® (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for treating neovascular or ‘wet’ age-related macular degeneration (nAMD), diabetic…
Genexine and EPD Biotherapeutics Merge to Enhance Drug Development Pipeline
Genexine (KOSDAQ: 095700), a Korean clinical-stage biopharmaceutical firm dedicated to developing innovative biologics for critical medical needs, has announced a merger with EPD Biotherapeutics (referred to as ‘EPD Bio’), a…
Unprecedented Opportunities: 265+ Collaborative and Licensing Deals in In-Vitro Diagnostics
The ‘In Vitro Diagnostic Collaboration and Licensing Deals 2016-2024’ report offers an extensive analysis and unprecedented access to collaboration and licensing agreements in the global biopharma industry. Updated and meticulously…
Owkin, an AI-Biotech Unicorn, Expands to Germany, Austria, and Switzerland to Accelerate Research with Cutting-Edge AI
Owkin, the first end-to-end AI-biotech unicorn specializing in AI-driven precision drug discovery, development, and diagnostics, has announced its expansion into the DACH region (Germany, Austria, and Switzerland). This follows partnerships…
Brenus Pharma Receives the BIG Start-up of the Year Award from French Tech Saint-Etienne Lyon
During its annual event “BIG UP,” French Tech Saint-Etienne Lyon awarded the BIG Start-up of the Year trophy to a start-up that exemplifies the region’s innovation and richness. French Tech…